Clinical Trial Update: Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213) [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing antiproteinuric effects of losartan potassium in non-diabetic proteinuric renal diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Disorder

Drugs mentioned

• Losartan Potassium (Losartan potassium)

Snippet

Sponsor: Organon and Co | Conditions: Renal Disorder | Phase 4 | Status: COMPLETED